Qualis Innovations, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 09, 2022 at 08:45 pm
Share
Qualis Innovations, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported net loss was USD 0.510529 million compared to USD 0.622777 million a year ago. Basic loss per share from continuing operations was USD 0.06 compared to USD 0.1 a year ago. Diluted loss per share from continuing operations was USD 0.06 compared to USD 0.1 a year ago.
For the six months, net loss was USD 0.605602 million compared to USD 0.826808 million a year ago. Basic loss per share from continuing operations was USD 0.07 compared to USD 0.15 a year ago. Diluted loss per share from continuing operations was USD 0.07 compared to USD 0.15 a year ago.
Qualis Innovations, Inc. is the holding company under which mPathix Health, Inc. (mPathix) operates. mPathix is a clinical-stage company focused on the development, production and distribution of pain management and other central nervous system-based solutions. It develops products designed to address the unmet needs of patients who seek alternatives to traditional pain medications and interventions or adjunctive therapies to their treatment regimen. Its product, which is its sole product and is in the development pipeline, is SOLACE, a non-invasive medical device that uses electromagnetic induction to generate deep heat below the surface of the skin to reduce and relieve pain. SOLACE delivers radio frequency (RF) energy continuously and thereby delivers thermal effects to the tissues and utilizes several differentiated features vs other RF devices on the market. SOLACE device is based on high-frequency magnetic induction technology, which it refers to as Electromagnetic Induction.
QUALIS INNOVATIONS, INC. 
